首页> 外文期刊>Annual Review of Physiology >Signaling for contraction and relaxation in smooth muscle of the gut.
【24h】

Signaling for contraction and relaxation in smooth muscle of the gut.

机译:肠道平滑肌收缩和松弛的信号。

获取原文
获取原文并翻译 | 示例
           

摘要

Phosphorylation of Ser19 on the 20-kDa regulatory light chain of myosin II (MLC20) by Ca2+/calmodulin-dependent myosin light-chain kinase (MLCK) is essential for initiation of smooth muscle contraction. The initial [Ca2+]i transient is rapidly dissipated and MLCK inactivated, whereas MLC20 and muscle contraction are well maintained. Sustained contraction does not reflect Ca2+ sensitization because complete inhibition of MLC phosphatase activity in the absence of Ca2+ induces smooth muscle contraction. This contraction is suppressed by staurosporine, implying participation of a Ca2+-independent MLCK. Thus, sustained contraction, as with agonist-induced contraction at experimentally fixed Ca2+ concentrations, involves (a) G protein activation, (b) regulated inhibition of MLC phosphatase, and (c) MLC20 phosphorylation via a Ca2+-independent MLCK. The pathways that lead to inhibition of MLC phosphatase by G(q/13)-coupled receptors are initiated by sequential activation of Galpha(q)/alpha13, RhoGEF, and RhoA, and involve Rho kinase-mediated phosphorylation of the regulatory subunit of MLC phosphatase (MYPT1) and/or PKC-mediated phosphorylation of CPI-17, an endogenous inhibitor of MLC phosphatase. Sustained MLC20 phosphorylation is probably induced by the Ca2+-independent MLCK, ZIP kinase. The pathways initiated by G(i)-coupled receptors involve sequential activation of Gbetagamma(i), PI 3-kinase, and the Ca2+-independent MLCK, integrin-linked kinase. The last phosphorylates MLC20 directly and inhibits MLC phosphatase by phosphorylating CPI-17. PKA and PKG, which mediate relaxation, act upstream to desensitize the receptors (VPAC2 and NPR-C), inhibit adenylyl and guanylyl cyclase activities, and stimulate cAMP-specific PDE3 and PDE4 and cGMP-specific PDE5 activities. These kinases also act downstream to inhibit (a) initial contraction by inhibiting Ca2+ mobilization and (b) sustained contraction by inhibiting RhoA and targets downstream of RhoA. This increases MLC phosphatase activity and induces MLC20 dephosphorylation and muscle relaxation.
机译:Ca2 + /钙调蛋白依赖性肌球蛋白轻链激酶(MLCK)对肌球蛋白II(MLC20)的20 kDa调节轻链上的Ser19进行磷酸化,对于启动平滑肌收缩至关重要。最初的[Ca2 +] i瞬变迅速消失,MLCK失活,而MLC20和肌肉收缩得到很好的维持。持续的收缩不能反映Ca2 +的致敏性,因为在不存在Ca2 +的情况下对MLC磷酸酶活性的完全抑制会诱导平滑肌收缩。星形孢菌素可抑制这种收缩,这意味着不依赖Ca2 +的MLCK参与。因此,与在实验上固定的Ca2 +浓度下激动剂引起的收缩一样,持续收缩涉及(a)G蛋白活化,(b)对MLC磷酸酶的调节抑制和(c)通过不依赖Ca2 +的MLCK进行的MLC20磷酸化。导致G(q / 13)耦合的受体抑制MLC磷酸酶的途径是由顺序激活Galpha(q)/ alpha13,RhoGEF和RhoA引发的,涉及Rho激酶介导的MLC调节亚基的磷酸化磷酸酶(MYPT1)和/或PKC介导的CPI-17(MLC磷酸酶的内源抑制剂)的磷酸化。持续的MLC20磷酸化可能是由不依赖Ca2 +的MLCK,ZIP激酶诱导的。由G(i)耦合的受体启动的途径涉及Gbetagamma(i),PI 3-激酶和不依赖Ca2 +的MLCK(整联蛋白连接的激酶)的顺序激活。最后的一种直接使MLC20磷酸化,并通过使CPI-17磷酸化来抑制MLC磷酸酶。 PKA和PKG介导松弛,在上游起作用以使受体(VPAC2和NPR-C)脱敏,抑制腺苷酸和鸟苷酸环化酶活性,并刺激cAMP特异性PDE3和PDE4以及cGMP特异性PDE5活性。这些激酶还在下游起作用,以通过抑制Ca2 +动员来抑制(a)初始收缩,以及(b)通过抑制RhoA和RhoA下游靶标来持续收缩。这增加了MLC磷酸酶的活性,并诱导MLC20的去磷酸化和肌肉松弛。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号